Navigation Links
Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis
Date:2/20/2009

nes, found in CLL. In 41 patients, MBL was confirmed by both methods.

The study, titled "B-Cell Clones as Early Markers for Chronic Lymphocytic Leukemia," (Vol. 360, No. 7, Feb. 12, 2009) was accompanied by the editorial "The Secret Lives of Monoclonal B Cells."

About Quest Diagnostics and Blood-based Tumor Testing

Quest Diagnostics is a leader in noninvasive blood-based biomarker testing used by physicians to screen for, diagnose and monitor carcinomas and other tissue-based disease. The company's proprietary Leumeta(TM) portfolio of tests helps physicians identify and analyze genetic components of leukemia and lymphoma tumors using blood plasma instead of bone marrow, which can only be tested after extraction through painful biopsy. In addition, the company is the exclusive national reference laboratory provider of the blood-based HE4 Ovarian Cancer Monitoring test, which is FDA cleared as an aid in monitoring recurrent or progressive disease in women with epithelial ovarian cancer. The company is also developing a molecular blood test based on Epigenomics AG's Septin 9 DNA methylation biomarker that can help physicians detect colorectal cancer based on a patient's blood specimen.

About Quest Diagnostics

Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at www.questdiagnostics.com.


'/>"/>
SOURCE Quest Diagnostics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
4. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
5. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
6. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
7. BioMosaics Glypican-3 Blood & Tissue Tests Receive CE Marking in Europe
8. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in Miami
9. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
10. Microlifes Home Blood Pressure Monitors Proven Accurate Even for Critical Patients
11. WaveSense Blood Glucose Meter One of Few Brands to Pass Rigorous TNO Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)...   DigiPath Labs , the cannabis testing subsidiary ... True North Laboratory of Ann Arbor, Michigan ... global supplier of diagnostic solutions for food-borne pathogens, to ... rapid diagnostic test kits to screen for food-borne pathogens ... joint effort is expected to result in the first ...
(Date:7/27/2015)... , July 28, 2015 CTI BioPharma Corp. ... to report its second quarter 2015 financial results on ... U.S. financial markets. Following the announcement, members of the ... discuss the results and provide a general corporate update ... the event can be obtained as follows: ...
(Date:7/27/2015)... , July 28, 2015   Regeneron Pharmaceuticals, ... a new global collaboration to discover, develop and commercialize ... immuno-oncology. As part of the agreement, the two companies ... (PD-1) inhibitor currently in Phase 1 testing and plan ... candidates based on ongoing, innovative preclinical programs. ...
Breaking Medicine Technology:DigiPath Labs Partners with Romer Labs to Validate Food-Borne Pathogen and Mycotoxin Testing Solutions for Cannabis 2DigiPath Labs Partners with Romer Labs to Validate Food-Borne Pathogen and Mycotoxin Testing Solutions for Cannabis 3CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 3Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 4Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 5Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 6Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 7Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 8
... WILMINGTON, N.C., Oct. 23 PPD, Inc. ... Sydney, Australia;,Copenhagen, Denmark; Lisbon, Portugal; and Lima, Peru; ... key therapeutic areas. The four new offices ... in response to increasing client demand. With,an office ...
... Blueprint for Future, WASHINGTON, Oct. 23 ... latest report from the,Association of Academic Health Centers ... trials in the U.S. and a blueprint for ... academic health,centers nationwide. The infrastructure for clinical trials ...
Cached Medicine Technology:PPD Opens Offices in Sydney, Australia; Copenhagen, Denmark; Lima, Peru; and Lisbon, Portugal 2AAHC Examines Nation's Clinical Trials Infrastructure 2
(Date:7/28/2015)... ... July 28, 2015 , ... ... has authorized the Company, from time to time and depending on market conditions, ... up to $25 million. Repurchases will be made in open market or privately ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... more common in shipbreaking workers than they are in the general population. Surviving ... to read it now. , Researchers at Taiwan’s National Health Research Institutes ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... a proprietary, web based clinical knowledge system, called “Referral Guidance.” , ... It provides physicians who are anticipating making a subspecialty referral an efficient means ...
(Date:7/28/2015)... ... , ... Women fear developing Alzheimer's disease more than having a heart attack ... are treatable, but there is little an individual can do to arrest the progress ... clinical trial, reports the July 2015 Harvard Women's Health Watch . , "There ...
(Date:7/28/2015)... ... July 28, 2015 , ... Fertility specialist Dr. Lisa ... Doctor 2015” by Atlanta Magazine. In Atlanta Magazine's annual Top Doctors issue, Dr. Hasty ... esteemed colleagues and peers in the metro area as one of the most respected ...
Breaking Medicine News(10 mins):Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Introducing Care to Care’s New Web Based “Referral Guidance” Program 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3
... Cancer is a common condition in India where beetle and ... found that certain bacteria’s excessive presence may give an early ... report published in the Open Access journal, Journal of Translational ... called squamous cell carcinoma) have six common species of ...
... affects young women and the condition// can sometimes be fatal. ... in the basal ganglia region of the brain. ,People ... and are unaware of the seriousness of their condition.When you ... the famous talented singer Karen Carpenter who died in the ...
... Oxidized phospholipids can be tested in blood to indicate the ... ,A report in the 7th July issue of New England ... phospholipids may indicate the amount of fatty build- up ... future be able to avoid the use of invasive ...
... British Columbia had showed that noise// might be not a ... so when that is effectively used to help the older ... the one sensation that comes in our way of concentration ... related to the disturbances that cause distractions in hearing something. ...
... role of fats, had been debated for a long// time. ... the between the various kinds of fats that are heart ... by banishing one kind of fat totally and taking only ... can help achieve the best possible diet for reducing cholesterol ...
... In a major breakthrough in the advancement of ... scan rare genetic mutation at a fraction of ... array diagonal gel electrophoresis. ,The technology devised ... in collaboration with Bristol, University college London, British ...
Cached Medicine News:Health News:PET Scan find the Area of Brain Responsible for Anorexia Nervosa 2Health News:PET Scan find the Area of Brain Responsible for Anorexia Nervosa 3
Sleek, all-metal head with large-diameter viewing window. 3X magnification....
Provides 30% more magnification and twice the field of view. Adjustable focus....
... FSE are a new series of cryostats ... outside of the cryochamber, which allows easy ... temperature adjustment. Simple, multi-lingual touch-screen display for ... the main touch-screen display. Angle of clamp ...
... Spectra photocoagulator delivers power and reliability ... (DPSS) technology. Diode side-pumping technology drives ... compact Novus Spectra system, and active ... output and system reliability from your ...
Medicine Products: